Move towards greater precaution on Covid vaccines follows figures on rare blood clots and low infection rates
People under 40 will be offered an alternative to the Oxford/AstraZeneca vaccine where possible and while infection rates remain low, following a recommendation from government advisers.
The move comes after the Joint Committee on Vaccination and Immunisation reviewed the speed and uptake of Covid vaccines in the UK and the latest figures on very rare blood clots after first shots of the Oxford/AstraZeneca vaccine.
